David P. Southwell, Director at PTC THERAPEUTICS, INC. (PTCT), sold 12,000 shares at $58.34 ($700K) on 2025-09-09, disclosed to the SEC on 2025-09-11.
Open-market sale of $700k PTCT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PTCT | SELL | 2023-04-04 | $257K | — | Filing → |
| PTCT | SELL | 2023-03-29 | $897K | — | Filing → |
| TCRX | BUY | 2022-05-20 | $90K | — | Filing → |